Alnylam Pharmaceuticals
Gowtham Yenduri, PhD, is a Scientist in Drug Product and Process Development at Alnylam Pharmaceuticals since July 2022, specializing in continuous manufacturing platforms for complex parenteral drug products. Previously, Gowtham served as a PhD Candidate at the University of Connecticut from September 2017 to April 2022, where expertise was developed in formulating and characterizing drug formulations and multidrug loaded liposomal formulations. Experience also includes an ORISE Fellowship at the FDA and leadership as President of the AAPS-UConn Student Chapter, organizing professional growth events. Prior roles encompass research assistant positions and regulatory analysis for medical device development, alongside contributions in quality assurance engineering during an internship at Medtronic. Gowtham holds a Master’s degree in Biomedical Engineering and a Bachelor's degree in Biomedical/Medical Engineering from the University of Connecticut.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.